This is an old revision of the document!
Protiva BioTherapeutics
Protiva BioTherapeutics was a Canadian biotechnology company based in Vancouver, British Columbia.
History
Protiva was founded in 2000 by Dr. Ian MacLachlan, a University of British Columbia researcher that contributed significantly to the development of the patented lipid nanoparticles later used in the COVID-19 vaccines developed by BioNTech and Moderna.